Please ensure Javascript is enabled for purposes of website accessibility

US Electric Vehicle Tax Breaks Will Expire on Sept. 30

16 hours ago

‘Reservoir Dogs’ and ‘Kill Bill’ Actor Michael Madsen Dies at 67

17 hours ago

Eyeing Arctic Dominance, Trump Bill Earmarks $8.6 Billion for US Coast Guard Icebreakers

17 hours ago

Trump’s Sweeping Tax-Cut and Spending Bill Wins Congressional Approval

18 hours ago

Americans Celebrate Their Independence With Record-Breaking Travel Numbers

21 hours ago

US Supreme Court to Decide Legality of Transgender School Sports Bans

21 hours ago

Nvidia Set to Become the World’s Most Valuable Company in History

22 hours ago

Poll: 41% in US ‘Extremely Proud’ to Be American, Near Historic Low

22 hours ago
Experimental COVID-19 Drug Cleared for Clinical Trials at Northern California Hospital
TLBBHMAP3-U010ALB5ANM-348f959abae2-512-300x300-1
By Jim Jakobs, Digital Producer
Published 5 years ago on
April 9, 2020

Share

“A promising investigational drug.”
Those words are being written quite a bit during these days as politicians, scientists, and the general public explore avenues for combating the COVID-19 pandemic.
Those same words were used in a press release from Saint Joseph Hospital in Humbolt County in announcing their participation in a new clinical trial of a drug developed by California-based Gilead Sciences.

Clinical Trials of Anti-Viral Drug Remdesivir

St Joseph Hospital in Eureka said in a news release that it is participating in two national clinical trials of the anti-viral drug remdesivir for the treatment of moderate and severe COVID-19. The experimental drug has shown promise in some recent emergency uses and patient trials.
“This is an important opportunity for future patients who present with COVID–19 at St. Joseph Hospital and meet certain criteria, to have access to remdesivir, a promising investigational drug,” said Dr. Roberta Luskin-Hawk, St. Joseph’s chief executive.
The hospital was chosen due to an established relationship with the principal investigator of the trial and was proactive in seeking accelerated approval for the trials in Humboldt.
Interest has been so great in remdesivir that the U.S. National Institutes of Health is expanding its study, which has nearly reached its initial goal of 440 patients. The NIH study is the most rigorous test. It compares remdesivir to placebo infusions, with neither patients nor doctors aware of who is getting which treatment until the end of the study.

How Remdesivir Works

Remdesivir is given through an IV. It’s designed to interfere with an enzyme that reproduces viral genetic material.
In animal tests against SARS and MERS, diseases caused by similar coronaviruses, the drug helped prevent infection and reduced the severity of symptoms when given early enough in the course of illness. It’s farther along in testing than many other potential therapies and current studies could lead to regulatory approval.
Online medical news site Stat News describes remdesivir this way: “The drug is designed to interfere with the process the virus, called SARS-CoV-2, uses to make copies of itself. The resulting copies of the virus lack their full RNA genome, so they can’t go on to replicate themselves or infect other cells.”
[covid-19-tracker]

‘Compassionate Use’ Allowed Under Emergency Regulations

In addition to patient trials, the U.S. Food and Drug Administration has authorized the use of remdesivir for treatment in a limited number of “compassionate use” cases.
“Gilead has given remdesivir to more than 1,700 patients on a case-by-case emergency basis, but more people ultimately will be helped if the company does the needed studies to prove safety and effectiveness,” Gilead chief executive Dan O’Day wrote in a open letter on the company’s website.
O’Day said the company has an inventory of 1.5 million doses, which could mean more than 140,000 treatment courses, depending on how long treatment needs to last. The company is providing the drug for free for now and has set a goal of making 500,000 treatment courses by October and more than a million by the end of the year.
Gilead supplied remdesivir for two studies in China expected to give results by the end of the month. It also launched two studies for hospitalized patients in the U.S., Asia, Europe and elsewhere.

Rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Gilead Sciences via AP)

A Remdesivir Recap With Mention of a ‘Red Flag’

“Stat News” recently reported on the trials and what might come next.
“Sometime this month, Chinese scientists will share results from two trials in that country, one looking at patients with severe Covid-19, and one with patients with mild and moderate infections,” the website reported.
“There is already one red flag. The investigators running the severe COVID-19 study in China have already taken an interim look at the data, but they did not stop the study early,” Stat News noted. “This suggests remdesivir isn’t working as well as hoped, and dampens optimism for an overall positive outcome.
“It’s also possible the trial will produce mixed results.”

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

July 4th Quiz: Test Your Knowledge of the Founding Fathers

DON'T MISS

Fresno Crash Involving Unlicensed Teen Driver Sends Woman to Hospital

DON'T MISS

Madre Fire Burns More Than 52,000 Acres in San Luis Obispo County

DON'T MISS

RIP John Harris: Fresno County Rancher, Racehorse Breeder Was a Visionary Leader Who Leaves a ‘Profound Legacy’

DON'T MISS

Valadao, Costa Spar on What Passage of Trump’s Bill Means for Medicaid Recipients

DON'T MISS

US Military Says 200 Marines Being Sent to Support ICE in Florida

DON'T MISS

Boeing Secures $2.8 Billion US Satellite Contract

DON'T MISS

Kaweah Health Names Its New Chief Nurse. She’s From Texas

DON'T MISS

Clovis Police Say At-Risk Missing Woman Found Dead in Mariposa County

DON'T MISS

Over 100 Former Senior Officials Warn Against Planned Staff Cuts at US State Department

UP NEXT

Madre Fire Burns More Than 52,000 Acres in San Luis Obispo County

UP NEXT

Kaweah Health Names Its New Chief Nurse. She’s From Texas

UP NEXT

Americans Celebrate Their Independence With Record-Breaking Travel Numbers

UP NEXT

San Luis Obispo’s Madre Fire Grows to 35,000 Acres, More Evacuations Ordered

UP NEXT

Poll: 41% in US ‘Extremely Proud’ to Be American, Near Historic Low

UP NEXT

Poorest Americans Dealt Biggest Blow Under Senate Republican Tax Package

UP NEXT

CHP Officer Dies in Line of Duty After Medical Emergency While on Patrol

UP NEXT

Downtown Housing Could Rise in Many California Cities, but Barriers Remain

UP NEXT

Valley Children’s Goes Into News Business to Highlight Stories at the Hospital

UP NEXT

Poll: Most Americans Say National Divide, Political Violence Threaten Democracy

RIP John Harris: Fresno County Rancher, Racehorse Breeder Was a Visionary Leader Who Leaves a ‘Profound Legacy’

13 hours ago

Valadao, Costa Spar on What Passage of Trump’s Bill Means for Medicaid Recipients

14 hours ago

US Military Says 200 Marines Being Sent to Support ICE in Florida

15 hours ago

Boeing Secures $2.8 Billion US Satellite Contract

15 hours ago

Kaweah Health Names Its New Chief Nurse. She’s From Texas

15 hours ago

Clovis Police Say At-Risk Missing Woman Found Dead in Mariposa County

15 hours ago

Over 100 Former Senior Officials Warn Against Planned Staff Cuts at US State Department

15 hours ago

US Electric Vehicle Tax Breaks Will Expire on Sept. 30

16 hours ago

‘Reservoir Dogs’ and ‘Kill Bill’ Actor Michael Madsen Dies at 67

17 hours ago

Fresno Police Recover Some of the $40,000 in Fireworks Stolen From Bullard High Team

17 hours ago

July 4th Quiz: Test Your Knowledge of the Founding Fathers

In the muggy summer of 1776, 56 men met in Philadelphia and pledged their “lives, fortunes, and sacred honor” to America’s future with the D...

23 minutes ago

23 minutes ago

July 4th Quiz: Test Your Knowledge of the Founding Fathers

A crash causes a traffic jam in northwest Fresno on Thursday, July 3, 2025. (GV Wire/Paul Marshall)
12 hours ago

Fresno Crash Involving Unlicensed Teen Driver Sends Woman to Hospital

The Madre Fire near New Cuyama has burned 52,593 acres with 5% containment, prompting evacuation orders in several San Luis Obispo County zones as of Thursday, July 3, 2025, afternoon. (CalFire)
13 hours ago

Madre Fire Burns More Than 52,000 Acres in San Luis Obispo County

13 hours ago

RIP John Harris: Fresno County Rancher, Racehorse Breeder Was a Visionary Leader Who Leaves a ‘Profound Legacy’

14 hours ago

Valadao, Costa Spar on What Passage of Trump’s Bill Means for Medicaid Recipients

An ICE agent talks with migrants about their scheduled appointments with U.S. Immigration and Customs Enforcement (ICE) on Father’s Day, to learn about their immigration status, in Chicago, Illinois., U.S., June 15, 2025. (Reuters File)
15 hours ago

US Military Says 200 Marines Being Sent to Support ICE in Florida

Boeing logo and miniature satellite model are seen in this illustration taken, March 10, 2025. (Reuters File)
15 hours ago

Boeing Secures $2.8 Billion US Satellite Contract

15 hours ago

Kaweah Health Names Its New Chief Nurse. She’s From Texas

Help continue the work that gets you the news that matters most.

Search

Send this to a friend